Methotrexate in the treatment of malignant tumours: evidence for the possible participation of host defence mechanisms.
D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D006968:Hypersensitivity, Delayed; D008214:Lymphocytes; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010950:Plasma Cells; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use
D013299:Streptodornase and Streptokinase; D008727:Methotrexate